NCT03123822

Brief Summary

We will be looking at 3 treatment arms in the form of different type of glasses to see if one is superior to helping kids have sustained a concussion and are symptomatic.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 13, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 21, 2017

Completed
6 months until next milestone

Study Start

First participant enrolled

October 31, 2017

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2021

Completed
9 months until next milestone

Results Posted

Study results publicly available

June 23, 2022

Completed
Last Updated

June 23, 2022

Status Verified

May 1, 2022

Enrollment Period

3.9 years

First QC Date

April 13, 2017

Results QC Date

November 22, 2021

Last Update Submit

May 27, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Convergence Insufficiency Symptom Survey

    This survey quantifies convergence insufficiency symptoms on a scale. The scale measures the severity of symptoms from the condition, convergence insufficiency. Score on a scale can range from 0 (least) to 60 (worst). This survey has been proven to be an effective and accurate gauge by previous research and study groups.

    Assessed up to 12 months

Secondary Outcomes (1)

  • Convergence Breaking Point at Near (Base Out Prism)

    Assessed up to 12 months

Study Arms (3)

Single vision glasses

EXPERIMENTAL

Typical glasses prescribed for children to correct only distance refractive error and to be worn all waking hours.

Device: Glasses

Single vision glasses with anti-glare coating

EXPERIMENTAL

Typical glasses prescribed for children to correct only distance prescription with anti-glare coating and to be worn all waking hours.

Device: Glasses

Eyezen

EXPERIMENTAL

Commercially available, low-powered, progressive addition lenses glasses with anti-glare coating to be worn all waking hours

Device: Glasses

Interventions

GlassesDEVICE

Glasses traditionally prescribed for refractive error

EyezenSingle vision glassesSingle vision glasses with anti-glare coating

Eligibility Criteria

Age9 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Sustained a concussion \> 6 weeks \< 16 weeks from date of initial visit
  • Criteria for concussion: formally diagnosed by physician
  • Minimum best corrected visual acuity: 20/25 in right and left eyes at distance and 20/30 both eyes at near
  • Minimum Stereopsis: 500" global
  • CISS score \> 16
  • Refractive error at least + 0.50D sphere or cylinder
  • Ability to clear \> 0.50 cycles per minute in monocular accommodative flipper of and binocular accommodative flipper of +/-1.50

You may not qualify if:

  • Diplopia from nerve palsies
  • Retinal pathology
  • Previous treatment of any amount of bifocal lenses and base in prism since concussion.
  • Vision therapy \> 6 weeks since concussion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama School of Optometry

Birmingham, Alabama, 35233, United States

Location

MeSH Terms

Conditions

Brain ConcussionOcular Motility Disorders

Interventions

Eyeglasses

Condition Hierarchy (Ancestors)

Brain Injuries, TraumaticBrain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemHead Injuries, ClosedWounds and InjuriesWounds, NonpenetratingCranial Nerve DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

LensesOptical DevicesEquipment and Supplies

Results Point of Contact

Title
Katherine Weise
Organization
UAB

Study Officials

  • Becky Luu, OD

    University of Alabama at Birmingham

    STUDY DIRECTOR
  • Katherine Weise, OD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Pediatric Optometry Services

Study Record Dates

First Submitted

April 13, 2017

First Posted

April 21, 2017

Study Start

October 31, 2017

Primary Completion

October 1, 2021

Study Completion

October 1, 2021

Last Updated

June 23, 2022

Results First Posted

June 23, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations